Literature DB >> 31212107

Frequency distribution, genotypes and prevalent sequence types of New Delhi metallo-β-lactamase-producing Escherichia coli among clinical isolates around the world: A review.

Masoud Dadashi1, Somayeh Yaslianifard2, Bahareh Hajikhani3, Kourosh Kabir4, Parviz Owlia5, Mehdi Goudarzi3, Mojdeh Hakemivala3, Davood Darban-Sarokhalil6.   

Abstract

OBJECTIVES: New Delhi metallo-β-lactamase (NDM)-producing Escherichia coli is perceived as one of the primary multidrug-resistant bacteria causing infections in hospitals and clinics. In this review, we present the frequency distribution, genotypes and most prevalent sequence types (STs) of NDM-producing E. coli among clinical isolates worldwide.
METHODS: Several international databases, including Medline, Embase, Scopus and Web of Science, were searched from 2008 to 2018 to identify studies addressing the prevalence of NDM-producing E. coli around the world.
RESULTS: Of 974 records identified from the databases, 110 studies fulfilled the eligibility criteria and were included in this analysis. The prevalence of NDM-producing E. coli was 82.6%, 12.9%, 1.5%, 1.0% and 2.0% in Asia, Europe, America, Africa and Oceania, respectively. The most common reported STs among NDM-producing E. coli were ST101, ST167, ST131, ST405, ST410 and ST648.
CONCLUSION: The spread of NDM variants among E. coli strains is a serious threat to global public health. In addition, the most prevalent E. coli clonal groups, such as ST101 and ST167, are one of the main causes of E. coli infection in different countries.
Copyright © 2019 International Society for Antimicrobial Chemotherapy. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Escherichia coli; NDM; New Delhi metallo-β-lactamase; Sequence type

Year:  2019        PMID: 31212107     DOI: 10.1016/j.jgar.2019.06.008

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  13 in total

Review 1.  Critical analysis of antibacterial agents in clinical development.

Authors:  Ursula Theuretzbacher; Karen Bush; Stephan Harbarth; Mical Paul; John H Rex; Evelina Tacconelli; Guy E Thwaites
Journal:  Nat Rev Microbiol       Date:  2020-03-09       Impact factor: 60.633

Review 2.  Epidemiology of β-Lactamase-Producing Pathogens.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

3.  Dissemination of carbapenemase-producing Enterobacterales in the community of Rawalpindi, Pakistan.

Authors:  Amina Habib; Stéphane Lo; Khanh Villageois-Tran; Marie Petitjean; Shaheen Akhtar Malik; Laurence Armand-Lefèvre; Etienne Ruppé; Rabaab Zahra
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

4.  Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae.

Authors:  Shampa Das; Adam Johnson; Laura McEntee; Nicola Farrington; Adam Kirby; Jennifer Unsworth; Ana Jimenez-Valverde; Ruwanthi Kolamunnage-Dona; Justine Bousquet; Laethitia Alibaud; Carole Sable; Magdalena Zalacain; Martin Everett; William Hope
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

5.  Co-Occurrence of NDM-5 and RmtB in a Clinical Isolate of Escherichia coli Belonging to CC354 in Latin America.

Authors:  Agustina Costa; Roque Figueroa-Espinosa; Florencia Gaudenzi; Nilton Lincopan; Bruna Fuga; Barbara Ghiglione; Gabriel Gutkind; José Di Conza
Journal:  Front Cell Infect Microbiol       Date:  2021-04-29       Impact factor: 5.293

6.  A Clinical Extensively-Drug Resistant (XDR) Escherichia coli and Role of Its β-Lactamase Genes.

Authors:  Mingyu Wang; Wenjia Wang; Yu Niu; Ting Liu; Ling Li; Mengge Zhang; Ziyun Li; Wenya Su; Fangyue Liu; Xuhua Zhang; Hai Xu
Journal:  Front Microbiol       Date:  2020-12-10       Impact factor: 5.640

7.  Presence of β-Lactamase-producing Enterobacterales and Salmonella Isolates in Marine Mammals.

Authors:  Olivia M Grünzweil; Lauren Palmer; Adriana Cabal; Michael P Szostak; Werner Ruppitsch; Christian Kornschober; Maciej Korus; Dusan Misic; Tanja Bernreiter-Hofer; Anna D J Korath; Andrea T Feßler; Franz Allerberger; Stefan Schwarz; Joachim Spergser; Elke Müller; Sascha D Braun; Stefan Monecke; Ralf Ehricht; Chris Walzer; Hrvoje Smodlaka; Igor Loncaric
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

8.  High Prevalence of CTX-M Type Extended-Spectrum Beta-Lactamase Genes and Detection of NDM-1 Carbapenemase Gene in Extraintestinal Pathogenic Escherichia coli in Cuba.

Authors:  Dianelys Quiñones; Meiji Soe Aung; Yenisel Carmona; María Karla González; Niurka Pereda; Mercedes Hidalgo; Mayrelis Rivero; Arnaldo Zayas; Rosa Del Campo; Noriko Urushibara; Nobumichi Kobayashi
Journal:  Pathogens       Date:  2020-01-16

9.  Integrating whole-genome sequencing within the National Antimicrobial Resistance Surveillance Program in the Philippines.

Authors:  David M Aanensen; Celia C Carlos; Silvia Argimón; Melissa A L Masim; June M Gayeta; Marietta L Lagrada; Polle K V Macaranas; Victoria Cohen; Marilyn T Limas; Holly O Espiritu; Janziel C Palarca; Jeremiah Chilam; Manuel C Jamoralin; Alfred S Villamin; Janice B Borlasa; Agnettah M Olorosa; Lara F T Hernandez; Karis D Boehme; Benjamin Jeffrey; Khalil Abudahab; Charmian M Hufano; Sonia B Sia; John Stelling; Matthew T G Holden
Journal:  Nat Commun       Date:  2020-06-01       Impact factor: 14.919

10.  Characterization of the IncFII-IncFIB(pB171) Plasmid Carrying bla NDM-5 in Escherichia coli ST405 Clinical Isolate in Japan.

Authors:  Yoko Takayama; Tsuyoshi Sekizuka; Hidehito Matsui; Yuzuru Adachi; Ryotaro Eda; Shin Nihonyanagi; Tatsuhiko Wada; Mari Matsui; Satowa Suzuki; Masashi Takaso; Hidero Kitasato; Makoto Kuroda; Hideaki Hanaki
Journal:  Infect Drug Resist       Date:  2020-02-18       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.